TrkB partial agonists: Potential treatment strategy for epilepsy, mania, and autism
- 1 January 2006
- journal article
- Published by Elsevier in Medical Hypotheses
- Vol. 66 (1) , 173-175
- https://doi.org/10.1016/j.mehy.2005.05.033
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Brain-derived neurotrophic factor as a drug target for CNS disordersEmerging Therapeutic Targets, 2004
- Conditional Deletion of TrkB but Not BDNF Prevents Epileptogenesis in the Kindling ModelNeuron, 2004
- Is mania caused by overactivity of central brain-derived neurotrophic factor?Medical Hypotheses, 2004
- Dopamine Partial AgonistsCNS Drugs, 2004
- Design of Potent Peptide Mimetics of Brain-derived Neurotrophic FactorJournal of Biological Chemistry, 2003
- Neurotrophins: Roles in Neuronal Development and FunctionAnnual Review of Neuroscience, 2001
- BDNF and epilepsy: too much of a good thing?Trends in Neurosciences, 2001
- Suppressed Epileptogenesis in BDNF Mutant MiceExperimental Neurology, 1995
- Neurotrophic factors and diseases of the nervous systemAnnals of Neurology, 1994
- Partial agonists, full agonists, antagonists: dilemmas of definitionTrends in Pharmacological Sciences, 1993